Spastic equinus foot: Multicenter study of the long-term results of tibial neurotomy

Neurosurgery

Volumn 55, Issue 5, 2004, Pages 1130-1136

  Buffenoir, Kevin ^a,b   Roujeau, Thomas ^a   Lapierre, Françoise ^b   Menei, Philippe ^c   Menegalli Boggelli, Dominique ^d   Mertens, Patrick ^e   Decq, Philippe ^a  

^a HENRI MONDOR HOSPITAL   (France)

^b POITIERS UNIVERSITY HOSPITAL   (France)

^c ANGERS UNIVERSITY HOSPITAL   (France)

^d NANTES UNIVERSITY HOSPITAL   (France)

^e HÔPITAL NEUROLOGIQUE   (France)

Author keywords

Functional neurosurgery; Gait analysis; Neurotomy; Peripheral nerves; Spasticity; Stretch reflex

Indexed keywords

ALCOHOL; BACLOFEN; BOTULINUM TOXIN; DANTROLENE; DIAZEPAM; LIPA SANTE; SPASMOLYTIC AGENT;

ARTICLE; CLAWTOE; CLINICAL TRIAL; FEMALE; FOLLOW UP; FOOT MALFORMATION; GAIT; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MYOTATIC REFLEX; NERVE SURGERY; NEUROTOMY; PES EQUINUS; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; SCORING SYSTEM; SHOE; SPASTIC EQUINUS FOOT; SPASTICITY; STATISTICAL SIGNIFICANCE; SURGICAL TECHNIQUE; TIBIAL NEUROTOMY; TREATMENT OUTCOME; TRICEPS SURAE MUSCLE; VARUS DEFORMITY; WALKING SPEED;

ADOLESCENT; ADULT; AGED; CHILD; EQUINUS DEFORMITY; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCLE SPASTICITY; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; TIBIAL NERVE; TIME;

EID: 8744240373     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.NEU.0000140840.59586.CF     Document Type: Article

References (44)

1. Ashworth B: Preliminary trial of carisoprodol in multiple sclerosis. Practitioner 192:540-542, 1964.
2. Bakheit AM, Thilmann AF, Ward AB, Poewe W, Wissel J, Muller J: A randomized, double-blind, placebo-controlled, dose-ranging study to compare the efficacy and safety of three doses of botulinum toxin type A (Dysport) with placebo in upper limb spasticity after stroke. Stroke 31:2402-2406, 2000.
3. Bewick GS, Tonge DA: Characteristics of end-plates formed in mouse skeletal muscles reinnervated by their own or by foreign nerves. Anat Rec 230:273-282, 1991.
4. Bohannon RW, Smith MB: Inter-rater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther 67:206-207, 1987.
5. Bohlega S, Chaud P, Jacob PC: Botulinum toxin A in the treatment of lower limb spasticity in hereditary spastic paraplegia. Mov Disord 10:399, 1995 (abstr).
6. Collins WF III, Mendell LM, Munson JB: On the specificity of sensory reinnervation of cat skeletal muscle. J Physiol 375:587-609, 1986.
7. Decq P: Peripheral neurotomies for the treatment of focal spasticity of the limb [in French]. Neurochirurgie 49:293-305, 2003.
8. Decq P, Cuny E, Filipetti P, Fève A, Keravel Y: Peripheral neurotomy for the treatment of spasticity: Indications, technique and outcome in the lower limbs [in French]. Neurochirurgie 44:175-182, 1998.
9. Decq P, Filipetti P, Cubillos A, Slavov V, Lefaucheur JP, Nguyen JP: Soleus neurotomy for treatment of the spastic equinus foot. Neurosurgery 47:1154-1160, 2000.
10. De Koning P, Verhaagen J, Sloot W: Org. 2766 stimulates collateral sprouting in the soleus muscle of the rat following partial denervation. Muscle Nerve 12:353-359, 1989.
11. Dengler R, Konstanzer A, Hesse S, Schubert M, Wolf W: Collateral nerve sprouting and twitch forces of single motor units in conditions with partial denervation in man. Neurosci Lett 97:118-122, 1989.
12. Dengler R, Neyer U, Wohlfarth K, Bettig U, Janzik HH: Local botulinum toxin in the treatment of spastic foot drop. J Neurol 239:375-378, 1992.
13. De Pava A, Meunier FA, Molg-Aoki KR, Dolly JO: Functional repair of motor endplates after botulinum neurotoxin type A poisoning: Biphasic switch of synaptic activity between nerve sprouts and their parent terminals. Proc Natl Acad Sci U S A 96:3200-3205, 1999.
14. Einsiedel LJ, Luff AR: Alterations in the contractile properties of motor units within the ageing medial gastrocnemius. J Neurol Sci 112:170-177, 1992.
15. Einsiedel LJ, Luff AR: Effect of partial denervation on motor units in the ageing rat medial gastrocnemius. J Neurol Sci 112:178-184, 1992.
16. Einsiedel LJ, Luff AR: Activity and motor unit size in partially denervated rat medial gastrocnemius. J Appl Physiol 76:2663-2671, 1994.
17. Einsiedel L, Luff AR, Proske U: Sprouting of fusimotor neurones after partial denervation of the cat soleus muscle. Exp Brain Res 90:369-374, 1992.
18. Fève A: Spasticity and botulinum toxin in 2003: An update [in French]. Neurochirurgie 49:265-270, 2003.
19. Gordon T, Yang JF, Ayer K, Stein RB, Tyreman N: Recovery potential of muscle after partial denervation: A comparison between rats and humans. Brain Res Bull 30:477-482, 1993.
20. Gros C: La chirurgie de la spasticité. Neurochirurgie 23:316-388, 1972.
21. Haimann C, Mallart A, Ferre JT: Patterns of motor innervation in the pectoral muscle of adult Xenopus laevis: Evidence for possible synaptic remodelling. J Physiol 310:241-256, 1981.
22. Hyman N, Barnes M, Bhakta B, Cozens A, Bakheit M, Kreczy-Kleedorfer B: Botulinum toxin (Dysport) treatment of hip adductor spasticity in multiple sclerosis: A prospective, randomised, double-blind, placebo controlled, dose-ranging study. J Neurol Neurosurg Psychiatry 68:707-712, 2000.
23. Juzans P, Comella JX, Molgo J: Nerve terminal sprouting in botulinum type - A treated mouse levator auris longus muscle. Neuromuscul Disord 6:177-185, 1996.
24. Kawabuchi M, Cintra WM, Deshpande SS: Morphological and electrophysiological study of distal motor nerve fiber degeneration and sprouting after irreversible cholinesterase inhibition. Synapse 8:218-228, 1991.
25. Kim YI, Lomo T, Lupa MT: Miniature end-plate potentials in rat skeletal muscle poisoned with botulinum toxin. J Physiol 356:587-599, 1984.
26. Lance JW: Symposium synopsis, in Koella WP (ed): Spasticity: Disordered Motor Control. Chicago, Year Book Medical Publishers, 1980, pp 485-494.
27. Lorenz F: Über chirurgische behandlung der angeborenen spastischen gliedstarre. Wien Klin Rdsch 21:25-27, 1887.
28. Mertens P, Sindou M: Selective peripheral neurotomies for the treatment of spasticity, in Sindou M, Abbott R, Keravel Y (eds): Neurosurgery for Spasticity. Wien, Springer-Verlag, 1991, pp 119-132.
29. Park DM, Shon SK, Kim YJ: Direct muscle neurotization in rat soleus muscle. J Reconstr Microsurg 16:379-383, 2000.
30. Piera JB, Robain G, Petit F, Kirsch JM: Ténotomie d'Achille et hémiplégie séquellaire: Résultats immédiats et à distance-A propos de 30 cas. Paris, Masson, 1999, pp 187-197.
31. Racette BA, Lopate G, Good L, Sagitto S, Perlmutter JS: Ptosis as a remote effect of therapeutic botulinum toxin B injection. Neurology 59:1445-1447, 2002.
32. Rafuse VF, Gordon T, Orozco R: Proportional enlargement of motor units after partial denervation of cat triceps surae muscles. J Neurophysiol 68: 1261-1276, 1992.
33. Rochel S, Robbins N: Effect of partial denervation and terminal field expansion on neuromuscular transmitter release and nerve terminal structure. J Neurosci 8:332-338, 1988.
34. Rotshenker S: Sprouting of intact motor neurons induced by neuronal lesion in the absence of denervated muscle fibers and degenerating axons. Brain Res 155:354-356, 1978.
35. Rotshenker S, Reichert F: Motor axon sprouting and site of synapse formation in intact innervated skeletal muscle of the frog. J Comp Neurol 193: 413-422, 1980.
36. Roujeau T, Lefaucheur JP, Slavov V, Gherardi R, Decq P: Long term course of the H reflex after selective tibial neurotomy. J Neurol Neurosurg Psychiatry 74:913-917, 2003.
37. Shaari CM, George E, Wu BL, Biller HF, Sanders 1: Quantifying the spread of botulinum toxin through muscle fascia. Laryngoscope 101:960-964, 1991.
38. Simpson DM, Alexander DN, O'Brien CF, Tagliati M, Aswad AS, Leon JM: Botulinum toxin type A in the treatment of upper extremity spasticity: A randomized, double blind, placebo-controlled trial. Neurology 46: 1306-1310, 1996.
39. Sindou M, Mertens P: Selective neurotomy of the tibial nerve for treatment of the spastic foot drop. Neurosurgery 23:738-744, 1988.
40. Snow BJ, Tsui JK, Bhatt MH, Varelas M, Hashimoto SA, Calne DB: Treatment of spasticity with botulinum toxin: A double blind study. Ann Neurol 28:512-515, 1990.
41. Stoffel A: The treatment of spastic contractures. Am J Orthop Surg 10:611-644, 1912.
42. Takenaga S, Kawahigashi Y, Sonoda Y, Horikiri T, Hirata K, Arimura K: Treatment of spastic paraparesis with botulinum toxin with reference to beneficial effects, disease severity and long term treatment [in Japanese]. Rinsho Shinkeigaku 35:251-255, 1995.
43. Thompson W, Jansen JK: The extent of sprouting of remaining motor units in partly denervated immature and adult rat soleus muscle. Neuroscience 2:523-535, 1977.
44. Yelnik A, Albert T, Bonan I, Laffont I: A clinical guide to assess the role of lower limb extensor overactivity in hemiplegic gait disorders. Stroke 30: 580-585, 1999.